Elizabeth E Reed insider trades: Travere Therapeutics (TVTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Elizabeth reports to the SEC
Open-market buys and sales
46 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TVTX | ↓ Sell | 37,500 | $62.34 | $2.3M | Direct | Sep 17, 2026 (2d) |
| May 6, 2026 | TVTX | ↓ Sell | 24,250 | $45.06 | $1.1M | Direct | May 6, 2026 (0d) |
| Apr 15, 2026 | TVTX | ↓ Sell | 51,500 | $41.29 | $2.1M | Direct | Apr 15, 2026 (0d) |
| Apr 1, 2026 | TVTX | ↓ Sell | 10,000 | $30.00 | $300K | Direct | Apr 2, 2026 (1d) |
| Mar 16, 2026 | TVTX | ↓ Sell | 10,000 | $28.09 | $281K | Direct | Mar 18, 2026 (2d) |
| Feb 17, 2026 | TVTX | ↓ Sell | 10,000 | $27.83 | $278K | Direct | Feb 19, 2026 (2d) |
| Feb 4, 2026 | TVTX | ↓ Sell | 2,994 | $32.18 | $96K | Direct | Feb 5, 2026 (1d) |
| Feb 3, 2026 | TVTX | ↓ Sell | 7,175 | $32.12 | $230K | Direct | Feb 3, 2026 (0d) |
| Jan 20, 2026 | TVTX | ↓ Sell | 10,000 | $27.34 | $273K | Direct | Jan 21, 2026 (1d) |
| Sep 22, 2025 | TVTX | ↓ Sell | 10,000 | $25.00 | $250K | Direct | Sep 24, 2025 (2d) |
| May 5, 2025 | TVTX | ↓ Sell | 4,920 | $21.05 | $104K | Direct | May 5, 2025 (0d) |
| Feb 12, 2025 | TVTX | ↓ Sell | 8,000 | $23.53 | $188K | Direct | Feb 12, 2025 (0d) |
| Feb 3, 2025 | TVTX | ↓ Sell | 8,951 | $19.78 | $177K | Direct | Feb 4, 2025 (1d) |
| Jan 22, 2025 | TVTX | ↓ Sell | 2,437 | $19.46 | $47K | Direct | Jan 23, 2025 (1d) |
| Sep 9, 2024 | TVTX | ↓ Sell | 4,387 | $11.52 | $51K | Direct | Sep 9, 2024 (0d) |
| Feb 1, 2024 | TVTX | ↓ Sell | 4,764 | $8.71 | $41K | Direct | Feb 2, 2024 (1d) |
| Jan 23, 2024 | TVTX | ↓ Sell | 2,062 | $8.96 | $18K | Direct | Jan 25, 2024 (2d) |
| Sep 5, 2023 | TVTX | ↓ Sell | 1,815 | $14.71 | $27K | Direct | Sep 5, 2023 (0d) |
| May 10, 2023 | TVTX | ↓ Sell | 825 | $16.59 | $14K | Direct | May 12, 2023 (2d) |
| Feb 1, 2023 | TVTX | ↓ Sell | 2,590 | $22.25 | $58K | Direct | Feb 2, 2023 (1d) |
| Jan 24, 2023 | TVTX | ↓ Sell | 2,062 | $21.50 | $44K | Direct | Jan 26, 2023 (2d) |
| May 12, 2022 | TVTX | ↓ Sell | 1,950 | $21.51 | $42K | Direct | May 12, 2022 (0d) |
| Jan 31, 2022 | TVTX | ↓ Sell | 1,350 | $27.40 | $37K | Direct | Feb 2, 2022 (2d) |
| Jan 24, 2022 | TVTX | ↓ Sell | 2,250 | $24.98 | $56K | Direct | Jan 26, 2022 (2d) |
| Jan 11, 2022 | TVTX | ↓ Sell | 5,000 | $27.40 | $137K | Direct | Jan 12, 2022 (1d) |
| Aug 17, 2021 | TVTX | ↓ Sell | 1,407 | $17.12 | $24K | Direct | Aug 17, 2021 (0d) |
| May 12, 2021 | TVTX | ↓ Sell | 3,250 | $19.30 | $63K | Direct | May 13, 2021 (1d) |
| Feb 8, 2021 | TVTX | ↓ Sell | 4,500 | $31.50 | $142K | Direct | Feb 9, 2021 (1d) |
| Feb 3, 2021 | TVTX | ↓ Sell | 3,175 | $28.91 | $92K | Direct | Feb 3, 2021 (0d) |
| Feb 2, 2021 | TVTX | ↓ Sell | 3,175 | $30.75 | $98K | Direct | Feb 2, 2021 (0d) |
| Jan 6, 2021 | TVTX | ↓ Sell | 1,376 | $26.83 | $37K | Direct | Jan 7, 2021 (1d) |
| Nov 16, 2020 | RTRX | ↓ Sell | 2,500 | $23.98 | $60K | Direct | Nov 17, 2020 (1d) |
| Nov 13, 2020 | RTRX | ↓ Sell | 2,500 | $23.62 | $59K | Direct | Nov 13, 2020 (0d) |
| Sep 23, 2020 | RTRX | ↓ Sell | 1,500 | $18.48 | $28K | Direct | Sep 23, 2020 (0d) |
| Sep 22, 2020 | RTRX | ↓ Sell | 1,500 | $18.59 | $28K | Direct | Sep 22, 2020 (0d) |
| May 12, 2020 | RTRX | ↓ Sell | 1,577 | $16.37 | $26K | Direct | May 13, 2020 (1d) |
| Mar 10, 2020 | RTRX | ↓ Sell | 3,500 | $15.02 | $53K | Direct | Mar 12, 2020 (2d) |
| Jan 8, 2020 | RTRX | ↓ Sell | 1,500 | $14.54 | $22K | Direct | Jan 8, 2020 (0d) |
| May 15, 2019 | RTRX | ↓ Sell | 1,050 | $17.73 | $19K | Direct | May 16, 2019 (1d) |
| Feb 12, 2019 | RTRX | ↓ Sell | 1,769 | $21.44 | $38K | Direct | Feb 13, 2019 (1d) |
| Jan 9, 2019 | RTRX | ↓ Sell | 1,500 | $23.95 | $36K | Direct | Jan 9, 2019 (0d) |
| Nov 15, 2018 | RTRX | ↓ Sell | 5,000 | $24.03 | $120K | Direct | Nov 16, 2018 (1d) |
| Jan 5, 2018 | RTRX | ↓ Sell | 942 | $24.04 | $23K | Direct | Jan 8, 2018 (3d) |
| Apr 10, 2006 | ANDS | ↓ Sell10b5-1 | 1,500 | $13.67 | $21K | Direct | Apr 11, 2006 (1d) |
| Feb 13, 2006 | ANDS | ↓ Sell10b5-1 | 1,500 | $10.84 | $16K | Direct | Feb 13, 2006 (0d) |
| Jan 9, 2006 | ANDS | ↓ Sell10b5-1 | 1,500 | $10.00 | $15K | Direct | Jan 11, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TVTX insiders
Open-market trades in the last 12 months
About Elizabeth E Reed's insider trades
Elizabeth E Reed is Chief Legal Officer and GC at Travere Therapeutics (TVTX). Since Jan 9, 2006, Elizabeth has reported no open-market purchases and 46 sales worth $9.3M on SEC Form 4. In the last 12 months: 9 sales ($7.0M).
3 sales (1% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (34 filings), option exercises (13 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TVTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.